Search alternatives:
material » materials (Expand Search)
Showing 821 - 840 results of 2,756 for search 'material dysfunction', query time: 0.11s Refine Results
  1. 821

    Arterial hypertension in tuberculosis patients: clinical course and pharmaceutical control by N. Yu. Klimenko, N. V. Drobotya, A. A. Kastanayan, V. V. Kaltykova, E. Sh. Guseynova

    Published 2007-10-01
    “…To access arterial hypertension (AH) prevalence, pathogenesis, and effectiveness of fixed-dose perindopril and indapamide combination in tuberculosis (TB) patients. Material and methods. In total, 489 case records of patients with TB of various localization were analyzed; 42 patients with TB and AH were examined. …”
    Get full text
    Article
  2. 822

    Organo-protective effects of a calcium antagonist nifedipine SR in elderly patients with isolated and systolo-diastolic arterial hypertension by V. E. Oleynikov, V. A. Budanova, S. S. Fadeeva, N. A. Borisova, E. E. Grishaeva, L. I. Gusakovskaya

    Published 1970-01-01
    “…To study clinical effectiveness of a calcium antagonist nifedipine SR in patients with various clinical variants of Stage I-II arterial hypertension (AH), aged over 60 years.Material and methods. An open, prospective, 48-week study included 48 patients with Stage I-II AH (mean age 66,15±4,81 years). …”
    Get full text
    Article
  3. 823
  4. 824

    Hemodynamic determinants of physical training effectiveness in rheumatoid arthritis patients by A. A. Zavodchikov, I. G. Krasivina, A. S. Noskova, A. A. Lavrukhina, S. M. Illarionova, S. V. Butusova

    Published 2007-08-01
    “…In patients with initial endothelial dysfunction, EDVD increased by 83% (p<0,05), in patients with normal endothelial function – by 5% (p>0,05). …”
    Get full text
    Article
  5. 825

    EFFECT OF PELVIC FLOOR MUSCLE BIOFEEDBACK ON IMPROVED ERECTILE FUNCTION IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS: PRELIMINARY STUDY by Astrid Meilinda, Herdiman Bernard Purba, Ponco Birowo, Aria Kekalih

    Published 2025-01-01
    “…Keywords: Biofeedback, erectile dysfunction, pelvic floor muscle exercises, lower urinary tract symptoms (LUTS). …”
    Get full text
    Article
  6. 826
  7. 827

    Galectin-3 and structural and functional left ventricular characteristics in coronary artery disease in combination with chronic kidney disease by S. S. Fateev, V. N. Oranzhereeva, V. K. Fedulov, E. V. Kovalenko, L. I. Markova, O. L. Belaya

    Published 2024-02-01
    “…An increase in Gal-3 concentration with worsening HF and correlations between the biomarker level and volume parameters, LV mass index, LV ejection fraction, GLS and diastolic dysfunction indicate its important role in the development of myocardial remodeling and fibrosis.…”
    Get full text
    Article
  8. 828
  9. 829

    BRAIN NATRIURETIC PEPTIDE AS BIOCHEMICAL MARKER FOR STRUCTURAL AND FUNCTIONAL HEART DISORDERS IN ARTERIAL HYPERTENSION by S. V. Ivanova, Yu. A. Vasyuk, E. Yu. Shupenina, P. V. Krikunov, I. A. Sadulaeva

    Published 2015-12-01
    “…The relation revealed for NTproBNP level and diastolic dysfunction of the LV by the data of transmitral and tissue Doppler-graphy. …”
    Get full text
    Article
  10. 830

    Sexual function and pelvic floor function in men with systemic sclerosis compared to healthy controls: a cross-sectional study by Barbora Heřmánková, Sabína Oreská, Maja Špiritović, Hana Štorkánová, Martin Komarc, Karel Pavelka, Ladislav Šenolt, Jiří Vencovský, Radim Bečvář, Michal Tomčík

    Published 2024-12-01
    “…Impaired SF was associated with higher disease activity, increased systemic inflammation, more pronounced fatigue, reduced physical fitness, severe depression, impaired overall quality of life, dyspepsia, and arthralgias (p < 0.05 for all).Conclusions Sexual dysfunction is highly prevalent in our SSc patients, whereas pelvic floor dysfunction is unlikely to be associated with these problems.…”
    Get full text
    Article
  11. 831
  12. 832
  13. 833

    The condition of the cardiovascular system in patients with relapsing-remitting multiple sclerosis by O. A. Traktirskaya, T. V. Adasheva, A. N. Boyko, E. V. Popova

    Published 2019-03-01
    “…In the group of patients with multiple sclerosis, there was an increase in C-reactive protein, the marker of endothelial dysfunction compared with the control group (p&lt;0.001). …”
    Get full text
    Article
  14. 834

    Feasibility of replacing 99mTc‐DTPA GFR measurements with eGFR from cystatin C in individuals with spinal cord injuries by Tatiana Kristensen, Peter S. Oturai, Bryan T. Haddock, Fin Biering‐Sørensen, Christina Kruuse, Ulrik B. Andersen

    Published 2025-05-01
    “…Using a fixed normal limit rather than an age‐corrected normal material for p‐cystatin C or eGFRCYS will misclassify many individuals as having chronic kidney disease.…”
    Get full text
    Article
  15. 835

    THE ROLE OF EPICARDIAL OBESITY IN THE DEVELOPMENT OF STRUCTURAL AND FUNCTIONAL REMODELING OF THE HEART by M. A. Druzhilov, Yu. E. Beteleva, O. Yu. Druzhilova, E. S. Andreeva, T. Yu. Kuznetsova

    Published 2017-05-01
    “…In the group of epicardial obesity patients there was more prevalentLV hypertrophy (25,9% (33,3%) vs 6,2% (7,4%), р&lt;0,01) and echo signs of diastolicLV dysfunction (74,8% vs 11,1%, р&lt;0,01).Conclusion. …”
    Get full text
    Article
  16. 836

    Role of microRNA in the risk stratification of ischemic strokes by Hosam M. Al-Jehani, Hosam M. Al-Jehani, Hosam M. Al-Jehani, Hosam M. Al-Jehani, Ahmed Hafez Mousa, Ahmed Hafez Mousa, Ahmed Hafez Mousa, Ahmed Hafez Mousa, May Adel Alhamid, Fawaz Al-Mufti

    Published 2025-02-01
    “…It can be used to identify Stroke-Specific microRNA Signatures, identify diagnostic and prognostic values, and regulate Vascular Inflammation, Endothelial Dysfunction, and Thrombus Formation and Resolution. …”
    Get full text
    Article
  17. 837

    ANTIISCHEMIC AND ANTIARRHYTHMIC EFFECTS OF SIMVASTATIN IN PATIENTS WITH DIASTOLIC HEART FAILURE by T. V. Pinchuk, Yu. N. Fedulaev, G. A. Khayretdinova

    Published 2013-12-01
    “…To assess the dynamics of antiischemic and antiarrhythmic effects of the 6-month simvastatin therapy (20 mg/d) in patients with ischemic chronic heart failure (CHF), arterial hypertension, and preserved left ventricular (LV) ejection fraction. Material and methods. The study included 125 patients with diastolic dysfunction (impaired relaxation and pseudonormalisation): 66 patients receiving standard CHF treatment and simvastatin (the main group), plus 59 patients receiving only standard CHF treatment (the control group). …”
    Get full text
    Article
  18. 838

    Endothelial function and structural markers of atherosclerosis: relationship in old and senile age by M. S. Troshina, A. N. Ryabikov, Yu. Yu. Palekhina, M. N. Ryabikov, S. K. Malyutina

    Published 2022-01-01
    “…Endothelial dysfunction (ED), intima-media thickness (IMT), and atherosclerotic plaques (ASPs) of the carotid arteries (CAs) are considered mutually associated markers of subclinical and clinical atherosclerosis. …”
    Get full text
    Article
  19. 839
  20. 840

    ASSOCIATION OF COAGULATION FACTORS WITH THE PRESENCE OF UNSTABLE ATHEROSCLEROTIC PLAQUES IN THE CORONARY ARTERIES by Yu. I. Ragino, E. V. Striukova, I. S. Murashov, Ya. V. Polonskaya, A. M. Volkov, E. V. Kashtanova, A. V. Kurguzov, A. M. Chernjavskii

    Published 2018-09-01
    “…This study was devoted to examinationof some factors of blood coagulation (factor II, factor VII, factor XII, antithrombin III) in order to find their associations with biomarkers of endothelial dysfunction (endothelin 1, monocyticchemoattractant protein type 1, MCP-1, lipoprotein (a), LP (a), adhesive molecules sVCAM-1, asymmetric dimethylarginin, ADMA, homocysteine), inflammation (interleukins, IL-6, IL - 8, C-reactive protein, CRP) and with unstable atherosclerotic plaques in the coronary arteries in men with coronary atherosclerosis.Material and methods. …”
    Get full text
    Article